07:00 , Apr 21, 2003 |  BC Week In Review  |  Company News

Alnis, Dyax deal

The companies will research and develop therapeutic peptides against an undisclosed cancer target from Alnis. DYAX will use its phage display technology to identify and characterize peptides that bind the target. The peptides may be...
07:00 , Apr 15, 2003 |  BC Extra  |  Company News

Dyax, Alnis cancer deal

The companies partnered to research and develop therapeutic peptides against an undisclosed cancer target from Alnis (Emeryville, Calif.). DYAX will use its phage display technology to identify and characterize peptides that bind to the target....